Prelude Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

Prelude Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-129,949	Closed	-$17.1M	–	2399
2018 Q4	$17.1M	Buy	129,949 +125,281	+2,684%	+$16M	1.15%	12
2018 Q3	$624K	Buy	4,668 +560	+14%	+$83.9K	0.04%	474
2018 Q2	$654K	Buy	+4,108	New	+$609K	0.04%	453
2014 Q4	–	Sell	-4,000	Closed	-$502K	–	2287
2014 Q3	$527K	Hold	4,000	–	–	0.07%	345
2014 Q2	$501K	Hold	4,000	–	–	0.07%	380
2014 Q1	$641K	Hold	4,000	–	–	0.09%	311
2013 Q4	$538K	Hold	4,000	–	–	0.09%	325
2013 Q3	$434K	Hold	4,000	–	–	0.07%	331
2013 Q2	$339K	Buy	+4,000	New	+$358K	0.07%	337

Prelude Capital Management's ATHN Position: Q1 2019 in Review

Prelude Capital Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 129,949 shares — an estimated $17.1M sold.

Prelude Capital Management first reported a position in ATHN in Q2 2013 and held it in 9 quarters. The position peaked at $17.1M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Prelude Capital Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Prelude Capital Management sold 129,949 Athenahealth, Inc. shares in Q1 2019, an estimated $17.1M.
Prelude Capital Management first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 9 quarters.
Prelude Capital Management's Athenahealth, Inc. position peaked at $17.1M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.